Books by Publisher: Washington Information Source — EbookNetworking.net

EbookNetworking 🔍 Search Books

📄 Lite AMP versionFull site ›

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

FDA keeps pressure on OTC drugs, bulk products. (Blood/Biologics).: An article from: Validation Times
Washington Information Source
View Details ›
INSPECTION LOG.(Food and Drug Administration's Freedom of Information Log)(Brief Article)(Directory): An article from: Inspection Monitor
Washington Information Source
View Details ›
CBER says firm's activator kit exceeds scope of the pharmacy practice.(Human drugs/Biologics): An article from: Validation Times
Dawn Gould
Washington Information Source
View Details ›
Preconfigured SAP systems seen speeding validation (1).(sampling and analysis plan)(Brief Article): An article from: Validation Times
Peter Dechnik
Washington Information Source
View Details ›
Validation specs should be drafted early, with aid of architects, engineers. (Renovations).: An article from: Validation Times
Elisa Ludwig
Washington Information Source
View Details ›
Medtronic Neurological draws 9-item 483 for design input, production process issues.(MEDICAL DEVICES): An article from: Inspection Monitor
Unavailable
Washington Information Source, Inc.
View Details ›
Failure to tell IRB of 4 deaths leads to 483s.(Institutional Review Board, Michael Jacoby, Mercy Ruan Neurology Clinic): An article from: Bioresearch Monitoring Alert
Washington Information Source
View Details ›
Chemrite, Fabre audits show GMP dearth at OTC drug firms.(OTC )(Brief Article): An article from: Validation Times
Washington Information Source
View Details ›
INSPECTION LOG.(inspection documents requested under Freedom of Information Act)(Brief Article): An article from: Inspection Monitor
Washington Information Source
View Details ›
Part 11 faults with lab equipment lift FDA concerns.(safety and security in pharmaceutical computer systems)(Brief Article): An article from: Validation Times
Peter Dechnik
Washington Information Source
View Details ›
OTC drug maker cited for failure to investigate deviations, provide GMP training.(Human Drugs): An article from: Validation Times
Unavailable
Washington Information Source, Inc.
View Details ›
Canada aims for 7-day approval for Phase I trials; rules redefine sponsors.(Canada): An article from: Bioresearch Monitoring Alert
Tamra Sami
Washington Information Source
View Details ›
Ensuring contractor lab validation falls to OTC drug maker, FDA concludes.(Burnham Laboratories): An article from: Validation Times
Wallace Witkowski
Washington Information Source
View Details ›
Medical journals' rule, IND reminders boosts Clinicaltrials.gov registrations.(Investigational New Drug): An article from: Bioresearch Monitoring Alert
Diane West
Washington Information Source
View Details ›
PPD Development receives 7-item 483 for stability, validation issues.: An article from: Inspection Monitor
Washington Information Source
View Details ›
Questionable OOS handling at American Pharm Partners raises eyebrows at FDA. (Human Drugs).: An article from: Inspection Monitor
Washington Information Source
View Details ›
INSPECTION LOG.(Brief Article): An article from: Inspection Monitor
Washington Information Source
View Details ›
INSPECTION LOG.(requests for inspection reports)(Brief Article): An article from: Inspection Monitor
Washington Information Source
View Details ›
BPD rule yields 35% jump in biologic adverse reports; labeling a leading cause.: An article from: Warning Letter Bulletin
Washington Information Source
View Details ›
Vaccine shortages abated, but FDA, CDC concerned about '01 outlook. (Food and Drug Administration, Centers for Disease Control and Prevention).(Brief Article): An article from: Validation Times
Ken Reid
Washington Information Source
View Details ›
Wyeth hit with 54-item 483 for OOS results, faulty aseptic results, HVAC.(Human drugs): An article from: Validation Times
Joseph Pickett
Washington Information Source
View Details ›
FDA envisions slight drop in audits for biologics, drugs in FY '06; device inspections to stay even.: An article from: Inspection Monitor
Joseph Pickett
Washington Information Source
View Details ›
New test method, training follow Kendall complaint.(inspection of Kendall Company's catheters and ventilation/tracheal tube)(Brief Article): An article from: Inspection Monitor
Washington Information Source
View Details ›
With sunsetting of 209 standard, question is if FDA will accept ISO 14644.(Brief Article): An article from: Validation Times
Ken Reid
Washington Information Source
View Details ›
USP workshop examines the role of bioassays in drug development.(Bioassays): An article from: Validation Times
Carrie Nathans
Washington Information Source, Inc.
View Details ›
3M's nod on 40-item 483 smooths future audits.(3M Pharmaceuticals)(Brief Article): An article from: Inspection Monitor
Washington Information Source
View Details ›
Food safety inspections may limit BiMo, foreign : Pre-approval NDA audits to get big cuts.(bioresearch monitoring)(new and abbreviated drug ... Article): An article from: Inspection Monitor
Washington Information Source
View Details ›
Inspection log.(from Food and Drug Administration in compliance with Freedom of Information Act)(Public Notice): An article from: Inspection Monitor
Washington Information Source
View Details ›
'Comparability protocols' touted as time-saving tools.(United States Food and Drug Administration on biologics industry)(Brief Article): An article from: Validation Times
Ellen Beck
Washington Information Source
View Details ›
Contract designer hit for having no design controls.(Brief Article): An article from: Validation Times
Washington Information Source
View Details ›
Industry seen liable for criminal, civil charges if CROs, investigators err.(contract research organization)(Brief Article): An article from: Bioresearch Monitoring Alert
Ellen Beck
Washington Information Source
View Details ›
'Pharmaceutical Inspectorate' and team inspections created for human, animal drugs: all Part 11 guidance, CPG revoked.: An article from: Inspection Monitor
Washington Information Source
View Details ›